United Kingdom · Biopharma startup
United Kingdom · Mereo Biopharma
Mereo is a new UK-based speciality biopharmaceutical company.
Funding reportedLast round: Post ipo equity
Follow Mereo Biopharma and see its new rounds in your feed.Start following
What company datasets say Mereo Biopharma raised
Funding, as reported
Reported in all387.5Min the source's currency
Rounds6
Last roundPost ipo equity
Last round dateJun 2024
Investors listed19
Founders and team
From Mereo Biopharma's own website: 15 on the team.
- Dr. Denise Scots-KnightChief Executive Officer
- Bharti NavsariwalaVice President, Head of Regulatory Affairs
- Dr. Ogün SazovaVice President, Clinical Development and Medical Affairs
- Christine FoxChief Financial Officer
- Dr. John LewickiChief Scientific Officer
- Wills Hughes-WilsonChief Patient Access and Commercial Planning
- Charles SermonGeneral Counsel and Business Development
- Dr. Anders EkblomNon-Executive Director
- Dr. Daniel ShamesNon-Executive Director
- Dr. Deepa PakianathanNon-Executive Director
- Dr. Jeremy BenderNon-Executive Director
- Dr. Pierre JacquetNon-Executive Director
- Justin RobertsNon-Executive Director
- Marc YoskowitzNon-Executive Director
- Michael WyzgaChairman
On a portfolio page
Investors who name them
Each firm lists Mereo Biopharma on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biopharma in United Kingdom
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Mereo Biopharma in front of investors. Or tell us what we have wrong.